Search

The Centers for Medicare & Medicaid Services created the Cell and Gene Therapy Access Model to be able to negotiate with manufacturers on behalf of states to make high-cost specialty drugs available to beneficiaries and affordable to State Medicaid Agencies. 

Per- and polyfluoroalkyl substances (PFAS) are a group of man-made chemicals that are associated with health detriments. Given the large scope of a planned multi-site study (MSS) and the complexity of the data to be collected, the Agency for Toxic…

The Abt team developed, implemented, and evaluated a communication campaign to increase education about and awareness of heart valve disease among the public, those at risk, and healthcare professionals.  

Despite growing evidence of the effectiveness of permanent supportive housing, local governments often have difficulty securing the necessary investments to expand the programs. The Ending Community Homelessness Coalition (ECHO), in partnership with the…

The U.S. Department of Housing and Urban Development (HUD) designed the Integrated Wellness in Supportive Housing (IWISH) model to help elderly adults in HUD-assisted multifamily housing age in place. New staff at IWISH sites—full-time Resident Wellness…

Among large cities, New York City (NYC) is unique due to the diversity of its more than 8 million residents. Residents come from a variety of countries,  speak multiple languages, have varying degrees of mobility and literacy, and live in a variety of…

Many medium and large cities in developing countries lack the capacity to adequately manage solid waste. Limited awareness of best practices for waste management and lack of access to key technical resources are key barriers to improvement. 

As part of a team with NORC, Abt conducted a mixed methods evaluation of the CMS ACO REACH Model and found savings and quality improvements.

Track PCC uses public health surveillance to learn more about the effects and burden of Long COVID among diverse populations.

Abt helped Maryland design and benchmark a statewide value based care model that saved $689 million and informed national health policy.